Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: A propensity score analysis  by Chiu, Fu-Chun et al.
A
C
DCoronary artery bypass graft surgery provides better survival in
patients with acute coronary syndrome or ST-segment elevation
myocardial infarction experiencing cardiogenic shock after
percutaneous coronary intervention: A propensity score analysis
Fu-Chun Chiu, MD,a,* Sheng-Nan Chang, MS, MD,a,* Jou-Wei Lin, MPH, MD, PhD,a
Juey-Jen Hwang, MD, PhD,a,b and Yih-Sharng Chen, MD, PhDb
Objective: The objective of this study was to find the best treatment strategy in patients who had acute coronary
syndrome and ST-segment elevation myocardial infarction sustaining cardiogenic shock.
Methods: Patients having cardiogenic shock owing to acute coronary syndrome and ST-segment elevation
myocardial infarction who required hemodynamic support with intra-aortic balloon counterpulsation were
retrospectively retrieved from the clinical information system in a tertiary medical center in Taiwan. A pro-
pensity score–based matching process was applied to find equalized groups with documented involvement
of more than 2 coronary vessels who received percutaneous coronary intervention only (PCI only group)
and who underwent subsequent coronary artery bypass graft surgery after percutaneous coronary interven-
tion (PCIþCABG group). A logistic regression model was used to find the factors associated with 30-day
mortality.
Results:The propensity analysis identified 44 patients in the PCI only group (35men, 65 2 years, and 9women,
75  4 years) and the other 44 patients in the PCIþCABG group (31 men, 67  2 years, and 13 women, 71  2
years) who had comparable baseline characteristics. The 30-day mortality, 40.9% in the PCI only group and
20.5% in the PCIþCABG group, was positively associated with percutaneous coronary intervention only
(odds ratio, 3.33; 95% confidence intervals, 1.14–10.0; P ¼ .03), increased age (odds ratio, 1.06 for each
year; 95% confidence intervals, 1.01–1.12; P ¼ .01) and a need to use extracorporeal membrane oxygenation
(odds ratio, 9.64; 95% confidence intervals, 2.19–42.4; P< .001).
Conclusions: This study has shown the survival benefit of surgical intervention in high-risk patients with acute
coronary syndrome or ST-segment elevation myocardial infarction who had cardiogenic shock after percutaneous
coronary intervention. (J Thorac Cardiovasc Surg 2009;138:1326-30)
ACQUIRED CARDIOVASCULAR DISEASECardiogenic shock complicates the course of 5% to 15% of
patients with acute myocardial infarction1-3 and accounts
for a large percentage of mortality from myocardial infarc-
tion.2,4 Initial stabilization of cardiogenic shock with intra-
aortic balloon pumping (IABP) was associated with a 20%
absolute risk reduction inmortality.5-7 The Global Utilization
of Streptokinase and Tissue Plasminogen Activator for Oc-
cluded Coronary Arteries (GUSTO)-1 trial and the Should
We Emergently Revascularize Occluded Coronaries for Car-
diogenic Shock (SHOCK) trial also showed that early revas-
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cardiogenic shock compared withmedical treatment alone.8,9
However, there is no consensus whether percutaneous
coronary intervention (PCI) or coronary artery bypass graft
surgery (CABG) results in better outcome. Some guidelines
suggest that primary PCI is preferred to CABG for patients
with 1- or 2-vessel coronary artery disease and technically
suitable lesions.10 Immediate CABG is the preferred treat-
ment for left main or severe 3-vessel disease. In the analysis
from the SHOCK trial, CABG and PCI were associated with
equivalent outcomes, although patients undergoing CABG
had more comorbid diseases such as diabetes and multive
ssel involvement.11 However, owing to the critical condi-
tions in the patients with cardiogenic shock, it is difficult,
if not impossible, to conduct a randomized trial to compare
the effects of emergency PCI or CABG.
Therefore, the objective of this study was to assemble pa-
tients having cardiogenic shock treated with either PCI only
or PCI with subsequent CABG (PCIþCABG) who were
comparable in baseline characteristics and disease severity
so as to determine the survival difference between the two
treatment strategies.urgery c December 2009




ACS ¼ acute coronary syndrome
ALKK ¼ Arbeitsgemeinschaft Leitende
Kardiologische Krankenhausarzte
CABG ¼ coronary artery bypass graft surgery
95% CI ¼ 95% confidence intervals
ECMO ¼ extracorporeal membrane oxygenation
GUSTO ¼ Global Utilization of Streptokinase
and Tissue Plasminogen Activator
for Occluded Coronary Arteries
IABP ¼ intra-aortic balloon pumping
OR ¼ odds ratio
PCI ¼ percutaneous coronary intervention
SHOCK ¼ SHould we emergently revascularize
Occluded Coronaries for cardiogenic
shock
STEMI ¼ ST-segment elevation myocardial
infarction
TIMI ¼ Thrombolysis In Myocardial Infarction
METHODS
Study Design
We conducted a nonrandomized study comparing survival between
patients with cardiogenic shock owing to ST-segment elevation myocar-
dial infarction (STEMI) or acute coronary syndrome (ACS) treated with
PCI only and PCIþCABG in a tertiary medical center in Taiwan. A pro-
pensity score method was used to elucidate factors associated with high
probability for getting CABG. The score was further applied to find sub-
sets within both groups so that potential covariates were comparable,
aiming to make retrospective study cohorts like an evenly distributed
randomized trial.
Subjects and Materials
Our institution, a 2400-bed university-affiliated tertiary teaching hospi-
tal equipped with a 227-bed intensive care unit and 40 emergency depart-
ment observatory units, is a tertiary referral center for cardiovascular
emergency. All the discharge notes during the period from 2002 to 2004
in the clinical information system were downloaded, and eligible patients
who had STEMI or ACS (unstable angina and non-STEMI) complicated
by cardiogenic shock caused by left ventricular dysfunction were retrieved.
Cardiogenic shock was defined by either clinical or hemodynamic data. The
clinical criteria included systolic blood pressure less than 90 mm Hg for
more than 1 hour not responsive to fluid administration alone and end-organ
hypoperfusion (urine output< 0.5 mL $ h1 $ kg1 or cool extremities).
Hemodynamic criteria included cardiac index below 2.2 L $ min1 $ m2
of body surface area and pulmonary capillary wedge pressure more than
18 mm Hg. Exclusion criteria were recent intracranial hemorrhage (<6
months), recent trauma or major operation, active bleeding, and unsuitabil-
ity for revascularization. Patients with a mechanical complication of myo-
cardial infarction such as ventricular septal defect, papillary muscle rupture,
or myocardial rupture were also excluded. The onset of shock had to be
within 36 hours of myocardial infarction. All patients received IABP and
PCI within 12 hours after onset of STEMI or after onset of symptoms of
cardiogenic shock in patients with ACS. The decision to undergo subse-
quent CABG after PCI in these patients remaining in shock depended on
the attending cardiologists’ discretion, clinical conditions, and the prefer-
ence of the family.The Journal of Thoracic and CDemographic, hemodynamic, and mortality data were also derived from
paper and electronic medical records. Laboratory data were retrieved from
the laboratory information system.
Propensity Score Methods
Propensity score matching is a method used to balance observed covari-
ates in the two treatment groups, that is, PCI only and PCIþCABG.12 In this
study, propensity score is the conditional probability for getting CABG, as
a binary dependent variable, under a set of measurements. All baseline char-
acteristics and parameters, potentially related to survival, were included in
a logistic regression model as covariates. This matching process made ob-
servational studies imitate a randomized trial and reduced selection bias
in the study cohorts.13
Age, sex, initial cardiac enzyme level (troponin I> 50 ng/mL or not),
Killip classification, left ventricular ejection fraction, hemoglobin level,
diabetes, hypertension, renal function, and the need for extracorporeal
membrane oxygenation (ECMO) were added into a nonparsimonious
multivariable logistic regression model to predict the decision to perform
CABG. The predicted probability derived from the logistic equation was
used as the propensity score for each individual.
Study Cohort Assembly
Patients with cardiogenic shock who received PCIþCABG therapy or
who received PCI only were pooled together and sorted according to their
propensity score in an ascending order. Subjects for whom an appropriate
match within an acceptable rank range could not be found were excluded
from further analysis.
Statistical Analysis
A logistic regression model was used to perform the propensity match
under SPSS 13.0 (SPSS Inc, Chicago, Ill). Odds ratio (OR) and 95% con-
fidence intervals (95% CI) were used to represent the predilection for a sub-
ject to be treated with CABG. Patients with lower and higher propensity
scores were excluded from further analysis if an appropriate match could
not be found. After the 1:1 matched groups were assembled, the propensity
scores of both PCIþCABG and PCI only groups were reported. Baseline pa-
tient characteristics were compared with c2 test (for categorical data) or with
the Student t test (for continuous variables). The c2 test was used to compare
the 30-day mortality between the two groups. Another logistic regression
model was used to find the factors, in addition to CABG, associated with
30-day mortality.
RESULTS
Initially, 86 patients receiving PCIþCABG and 69 patients
receiving PCI only owing to multiple-vessel diseases and
cardiogenic shock were enrolled. Age was 66.7 11.1 years
in the PCIþCABG group and 67.6  13.8 years in the PCI
only group (Table 1). The average time from symptom onset
to shock was 7.2 7.0 hours in the PCI group and 5.7 5.4
hours in the PCIþCABG group. There were no significant
differences between the two groups (P ¼ .275). Mortality
rate was statistically lower in the CABG group at 7 days
(11.1% vs 21.4%; P ¼ .02) and 30 days (17.1% vs
35.7%; P< .001).
Propensity analysis showed the odds with which a patient
would or would not receive subsequent CABG if certain
clinical characteristics existed. Vessel condition (3-vessel
disease or left main involvement) was shown to be one of
the determining factors that led to subsequent CABG (OR,ardiovascular Surgery c Volume 138, Number 6 1327
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D2.4; P ¼ .003; 95% CI, 0.14–4.2). Initial left ventricular
ejection fraction less than 40% (OR, 0.34; P ¼ .059; 95%
CI, 0.11–1.04) and initial troponin I more than 50 ng/mL
(OR, 0.43; P ¼ .084; 95% CI, 0.17–1.11) were less prone
to require CABG, with a borderline significance. Parameters
such as sex, age, renal function, diabetes, hypertension,
ECMO use, non-STEMI, or STEMI did not seem to affect
the decision in choosing CABG. All the predictors remained
in the model and were used to calculate the propensity score
for CABG. Propensity score was 0.6543  0.1971 in pa-
tients receiving CABG and 0.4421  0.2040 in patients re-
ceiving PCI. The propensity in predisposing to the selection
of CABG was statistically significant (P< .001).
The propensity score–matching process selected 44 pa-
tients receiving PCIþCABG and the other 44 patients receiv-
ing PCI only for further analysis. The average time of CABG
after PCI in PCIþCABG group was 2.8 days, a range from 1
to 19 days. Twenty patients received cardioplegic arrest and
on-pump CABG, and the others received beating-heart and
off-pump CABG. The average number of revascularized
vessels via initial PCI was 1.3 (3-vessel revascularization
in 3 patients, 2 vessels in 22, and 1 vessel in 63). The average
number of revascularized vessels via subsequent CABGwas
2.6 (3 vessels in 28 patients and 2 vessels in 16). There were
4 patients with moderate to severe mitral insufficiency in the
PCI group and 2 patients with moderate to severe mitral in-
sufficiency in the PCIþCABG group. One patient received
mitral valve repair during CABG. The mean age was 68.5
TABLE 1. Baseline characteristics and mortality in patients with PCI
and subsequent CABG orwith PCI only, before propensityscore–based
matching
PCIþCABG PCI only P value
No. of patients 86 69
Age (y) 66.7  11.1 67.6  13.8 .63
Male (%) 72.1 76.8 .58
Hypertension (%) 38.4 49.3 .19
Diabetes mellitus (%) 32.6 36.2 .73
Troponin I>50 (%) 36.0 49.3 .25
LVEF<40% (%) 82.6 69.6 .14
Killip .02
I or II (%) 24.4 24.6
III (%) 25.6 36.2
IV (%) 46.5 39.1
ECMO use (%) 15.1 10.1 .36
Diseased vessel .002
Two-vessel disease (%) 17.4 42.0
Three-vessel disease (%) 54.7 44.9
LMþ3-vessel disease (%) 27.9 13.0
LVEF (%) 36.4  11.2 33.5  13.7 .52
Hemoglobin (g/dL) 12.0  2.0 11.8  2.0 .73
Creatinine (mg/dL) 1.6  1.5 3.1  11.4 .26
Propensity score 0.6453  0.1971 0.4421  0.2040 <.001
PCI, Percutaneous coronary intervention;CABG, coronary artery bypass graft surgery;
LVEF, left ventricular ejection fraction; ECMO, extracorporeal membrane oxygena-
tion; LM, left main coronary artery.1328 The Journal of Thoracic and Cardiovascular S 10.1 years in the PCIþCABG group and 67.0 141 years
in the PCI only group (P¼ .57). The percentage of initial tro-
ponin I more than 50 ng/mL and the percentage of initial left
ventricular ejection fraction less than 40% were similar in
both groups (P ¼ .97 and P ¼ .40, respectively). The distri-
bution of vessel status and other baseline characteristics
were comparable (Table 2). Propensity score was 0.5363
 0.1807 in the PCIþCABG group and 0.5355  0.1809
in the PCI only group (P ¼ .98).
The 7-day mortality was of no significant difference be-
tween the PCIþCABG and the PCI only groups (15.9% vs
25%; P¼ .29). The 30-day mortality was statistically lower
in the PCIþCABG group (20.5% vs 40.9%; P ¼ .03). Mul-
tivariate logistic regression model found that the 30-day
mortality was negatively associated with CABG (OR,
0.30; 95% CI, 0.10–0.88; P¼ .03) and positively associated
with increased age (OR, 1.06 for each year; 95% CI, 1.01–
1.12; P¼ .01) and a need to use ECMO (OR, 9.64; 95% CI,
2.19–42.4; P< .001).
DISCUSSION
Although patients with more coronary vessel involvement
and less extent of myocardial damage were prone to under-
going CABG, the results of this study have demonstrated an
TABLE 2. Baseline characteristics and mortality in patients with PCI
and subsequent CABG or with PCI only, after propensity score–based
matching
PCIþCABG PCI only P value
No. of patients 44 44
Propensity scores 0.5363  0.1807 0.5355  0.1809 .98
Age (y) 68.5  10.1 67.0  14.1 .57
Male (%) 79.5 70.5 .46
Hypertension (%) 45.5 43.2 .83
Diabetes mellitus (%) 38.6 34.1 .66




Unknown (%) 77.3 86.4
Killip .72
I or II (%) 27.3 20.5
III (%) 27.3 29.5
IV (%) 45.5 50.0
ECMO use (%) 13.6 15.9 .76
Diseased vessel .44
Two-vessel disease (%) 25.0 34.1
Three-vessel disease (%) 59.1 45.5
LMþ3-vessel disease (%) 15.9 20.5
LVEF (%) 32.8  11.1 29.6  14.4 .62
Hemoglobin (g/dL) 12.1  2.1 12.0  2.1 .77
Creatinine (md/dL) 1.7  1.5 1.7  1.2 .98
PCI, Percutaneous coronary intervention;CABG, coronary artery bypass graft surgery;
LVEF, left ventricular ejection fraction; ECMO, extracorporeal membrane oxygena-
tion; LM, left main coronary artery.urgery c December 2009
Chiu et al Acquired Cardiovascular Disease
A
C
Dobserved survival benefit in the patients with cardiogenic
shock receiving PCI and subsequent CABG. In the propen-
sity analysis, PCI followed by CABG has still provided sur-
vival benefit over PCI only.
The postoperative mortality in cardiogenic shock has been
documented principally as a result of delay of operation (be-
yond 18 hours) leading to progression of preoperative organ
failure or progression of underlying cardiac disease.14 Our
patients received revascularization by PCI within 12 hours
after STEMI or 12 hours after shock in non–ST-elevated
ACS. The early intervention in our patients (average time
of CABG after PCI was 2.8 days) made the 30-day mortality
not inferior to prior studies.
In the GUSTO-I study, the 30-day mortality in the 406 pa-
tients who underwent early catheterization was 38%.8 In the
SHOCK trial, the 30-day mortality rate in early revasculari-
zation patients was 46.7%.9 Our patients treated with PCI
only had the same mortality rate (40.9%) as reported in pre-
vious large trials, but the patients treated with PCIþCABG
had a lower mortality rate (20.5%). In the SHOCK registry,
CABG and PCI were associated with equivalent outcomes
even if there was significantly more comorbidity (diabetes
and multivessel diseases) in the CABG group.11 The similar
outcomes, despite the worse condition in patients undergo-
ing CABG, may reflect in part the higher rate of complete re-
vascularization (CABG 87% vs PCI 23%).11 In our study,
patients in both groups received early revascularization by
immediate IABP and emergency PCI after cardiogenic
shock. The ability to achieve further complete revasculariza-
tion by CABGmay explain the better outcome in this group,
given equal left ventricular function and diseased vessel sta-
tus in both groups.
The in-hospital mortality after PCI in cardiogenic shock is
related to the degree of reperfusion achieved in the infarct-
related artery.4,15 Among 276 patients in the nonrandomized
SHOCK registry undergoing PCI, the mortality for Throm-
bolysis In Myocardial Infarction (TIMI) 3, TIMI 2, and
TIMI 1/0 flow was 33%, 50%, and 86%, respectively.15
A report from the Arbeitsgemeinschaft Leitende Kardiologi-
sche Krankenhausarzte (ALKK) primary PCI registry in
Germany also demonstrated the same mortality relationship
to TIMI flow.16 Although we did not have thallium or coro-
nary angiographic images after CABG, complete revascular-
ization was one of the reasonable explanations of better
survival.
Remote muscle contraction maintained cardiac contractil-
ity in myocardial infarction. Improved availability of vessels
was a key element toward secondary salvage of remote mus-
cle, which carried the day in relationship to survival. Allen
and associates17 reported that surgical intervention at the
time of acute myocardial infarction, using controlled reper-
fusion, salvaged contractile recovery of regions supplied
both by the infarct vessel and by remote muscle. As com-
pared with CABG, PCI seems to cause more dyskinetic non-The Journal of Thoracic and Creperfused segments to develop akinesis and thereby renders
the infarct-related muscle unable to recover.17 The subse-
quent CABG after PCI might have benefit to the remote
muscle. Besides, the infarct-related region may have lost
function (immediately after the acute myocardial infarction),
progressively dilated, and impaired remote muscle function
owing to geometric process.18 Surgical intervention by
CABG with ventricular restoration is reported to reduce
late mortality and morbidity. Although our patients did not
receive ventricular restoration, the timely surgical interven-
tion provided an alternative treatment option in cardiogenic
shock.
The analysis in our propensity score–matched study
showed that CABG was an independent factor associated
with better outcome, but old age and ECMO use were asso-
ciated with worse outcome. In the SHOCK registry, the
notable exception of higher survival with early revasculari-
zation was a differential treatment effect by age.19 The youn-
ger patients (<75 years old) derived a large benefit from
early revascularization, in contrast to an apparent lack of
benefit for those 75 years of age and older. We also demon-
strated that age was one of the important independent factors
associated with worse survival in our study, compatible with
the SHOCK registry. Because the number of patients with
age equal to or more than 75 years was not large enough
in our cohort, we were conservative to conclude that
PCIþCABG was still better than PCI only in the elderly
patients.
The fact that ECMO use was associated with a poor out-
come might be related to more severe conditions in the
patients who needed it. Besides, ECMO use provided no
benefit to coronary blood flow, and it only earned ‘‘addi-
tional time’’ for physicians to achieve complete revascular-
ization in cardiogenic shock.20 In previous studies, patients
in cardiogenic shock on admission had higher in-hospital
mortality than those in whom shock developed after hospi-
talization.21,22 However, in our analysis, the initial Killip
classification was not an independent factor related to sur-
vival once the cardiogenic shock later developed.
Limitations
The propensity analysis would exclude the patients with
high or low propensity score owing to lack of adequate con-
trol. Further studies will be needed to find the optimal mode
of revascularization in those who are at an extreme risk so
that CABG is the last resort and in those whose hemodynam-
ics can be maintained so that CABG will not be considered
a necessity We found that increased vessel involvement (3-
vessel and left main disease) was more likely to necessitate
CABG, and some of these patients with a high propensity
score might have been excluded.
In addition, we considered that all of the patients having
cardiogenic shock after PCI and requiring IABP had very
grave hemodynamic conditions. Possible prognostic factorsardiovascular Surgery c Volume 138, Number 6 1329
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Dat the moment, such as general conditions, vessel conditions,
and comorbid conditions (eg, renal function), were matched
by propensity score. The remaining factors that led to the
decision for CABG were family preference, financial
problems, and social stigma, which we assumed were not
associated with the outcome. However, this propensity-
score–based method cannot replace the evidence provided
by a full-scale randomized trial. Further prospective studies
may be needed to further examine our results.
CONCLUSIONS
This study has demonstrated the survival benefit of surgi-
cal intervention in the high-risk patients with ACS or
STEMI who had cardiogenic shock and required IABP after
PCI. Further studies will be needed to identify the mecha-
nism of benefit of surgical intervention, such as complete
revascularization.
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